DICL_CP_0308159 - DICL Database

Basic Molecular Information

Basic Information

DICL ID

DICL_CP_0308159

PubChem CID

16666

Molecular Formula

C₁₀H₂₀O

Molecular Weight

156.269 g/mol

Synonyms/Alias

[l-Menthol; (-)-menthol; 2216-51-5; Levomenthol; l-(-)-Menthol; Menthomenthol; (1R;2S;5R)-2-Isopropyl-5-methylcyclohexanol; Menthacamphor; Peppermint camphor; (1r;2s;5r)-(-)-menthol; U.S.P. Menthol; L...[l-Menthol; (-)-menthol; 2216-51-5; Levomenthol; l-(-)-Menthol; Menthomenthol; (1R;2S;5R)-2-Isopropyl-5-methylcyclohexanol; Menthacamphor; Peppermint camphor; (1r;2s;5r)-(-)-menthol; U.S.P. Menthol; Levomentholum; Racementhol; Hexahydrothymol; (-)-Menthyl alcohol; Menthol racemic; (1R)-(-)-Menthol; d;l-Menthol; (-)-(1R;3R;4S)-Menthol; (R)-(-)-Menthol; 89-78-1; D-(-)-Menthol; Cyclohexanol; 5-methyl-2-(1-methylethyl)-; (1R;2S;5R)-; p-Menthan-3-ol; (-)-trans-p-Menthan-cis-ol; rac-Menthol; 1-Menthol; (L)-MENTHOL; Menthol(-); (1R;2S;5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol; Menthol natural; Menthol; (1R;3R;4S)-(-)-; (1R;3R;4S)-(-)-MENTHOL; Menthol; dl-; NCI-C50000; Cyclohexanol; 5-methyl-2-(1-methylethyl)-; (1R;2S;5R)-rel-; 1R-Menthol; NSC 62788; Racemic menthol; Water-soluble menthol; (1R;2S;5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol; (1R;2S;5R)-Menthol; 5-Methyl-2-(1-methylethyl)cyclohexanol; BZ1R15MTK7; (1R;2S;5R)-5-methyl-2-(1-methylethyl)cyclohexanol; (+/-)-Menthol; (1R-(1-alpha;2-beta;5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol; CHEMBL470670; YS08XHA860; DTXSID1020805; DTXSID1022180; CHEBI:15409; NSC2603; (1R;2S;5R)-2-isopropyl-5-methyl-cyclohexanol; Headache crystals; NSC-2603; (1R;2S;5R)-2-isopropyl-5-methylcyclohexan-1-ol; FEMA No. 2665; MFCD00062979; NSC-62788; Menthol (VAN); Racementholum; Thymomenthol; Menthol; cis-1;3;trans-1;4-; Racementol; l-Menthol (natural); NSC 2603; (+-)-Menthol; I-menthol; Menthol racemique; Levomenthol; (-)-Menthol; Levomenthol [INN:BAN]; Racementhol [INN:BAN]; Cyclohexanol; 5-methyl-2-(1-methylethyl)-; [1R-(1.alpha.;2.beta.;5.alpha.)]-; Menthol natural; brazilian; Menthol; l-; Racementol [INN-Spanish]; rel-(1R;2S;5R)-2-Isopropyl-5-methylcyclohexanol; Levomentholum [INN-Latin]; Menthol racemique [French]; Racementholum [INN-Latin]; DTXCID802180; Tra-kill tracheal mite killer; (1alpha;2beta;5alpha)-5-methyl-2(1-methylethyl)cyclohexanol; DTXCID101305276; MEGGEZONE; CAS-89-78-1; CCRIS 375; CAS-2216-51-5; l-Menthol (TN); CCRIS 3728; CCRIS 4666; HSDB 5662; SR-05000001936; (-)-p-Menthan-3-ol; EINECS 201-939-0; EINECS 218-690-9; EINECS 239-388-3; UNII-BZ1R15MTK7; (1R;2S;5R)-rel-2-Isopropyl-5-methylcyclohexanol; BRN 1902288; BRN 3194263; levomentol; UNII-YS08XHA860; (+-)-(1R*;3R*;4S*)-Menthol; AI3-52408; Cyclohexanol; 5-methyl-2-(1-methylethyl)-; (1.alpha.;2.beta.;5.alpha.)-; Cyclohexanol; 5-methyl-2-(1-methylethyl)-; (1R-(1alpha;2beta;5alpha))-; CYCLOHEXANOL; 5-METHYL-2-(1-METHYLETHYL)-; (1R-(1.ALPHA.;2.BETA.;5.ALPHA.))-; L-Menthol natural; 1 -menthol; NCGC00159382-02; 98167-53-4; L-MENTHOLUM; l-Menthol (JP17); Spectrum_000305; LEVOMENTHOL [II]; MENTHOL [MI]; 5-Methyl-2-(1-methylethyl)cyclohexanol; (1alpha;2beta;5alpha)-; L-MENTHOL [JAN]; Menthol; (+/-)-; Spectrum2_000855; Spectrum3_001561; Spectrum5_001060; LEVOMENTHOL [INN]; RACEMENTHOL [INN]; M0545; DL-MENTHOL [JAN]; Menthol;3;trans-1;4-; LEVOMENTHOL [HSDB]; RACEMENTHOL [HSDB]; pound - pound(c)-Menthol; EC 201-939-0; EC 218-690-9; SCHEMBL4613; (1R;2S;5S)-2-Isopropyl-5-methyl-cyclohexanol; BSPBio_003062; KBioSS_000785; LEVOMENTHOL [WHO-DD]; 2-06-00-00052 (Beilstein Handbook Reference); 4-06-00-00151 (Beilstein Handbook Reference); MLS002207256; DivK1c_000820; MENTHOL RACEMATE [MI]; SPECTRUM1503134; Menthol;3R;4S)-(-)-; SPBio_000869; GTPL2430; NPO-11; (-)-Menthol; USP; 97%; HMS502I22; KBio1_000820; KBio2_000785; KBio2_003353; KBio2_005921; KBio3_002562; NOOLISFMXDJSKH-KXUCPTDWSA-; (-)-Menthol; analytical standard; NINDS_000820; Cyclohexanol; 5-methyl-2-(1-methylethyl)-; (1R;3R;4S)-; HMS1922G13; HMS2092L14; HMS3885J18; LEVOMENTHOL [EP MONOGRAPH]; Pharmakon1600-01503134; NSC62788; L-Menthol; >=99%; FCC; FG; Tox21_111620; Tox21_201823; Tox21_201919; Tox21_202608; Tox21_302999; Tox21_303028; WLN: L6TJ AY1&1 BQ D1; BDBM50318482; CCG-40300; Cyclohexanol; 2-isopropyl-5-methyl-; Cyclohexanol; 5-methyl-2-(1-methylethyl)-; (1alpha;2beta;5alpha)-; NSC758395; s4714; AKOS016842647; (1R; 2S; 5R-)-(-)-Menthol; 1ST1669; BS-3863; DB00825; LMPR0102090001; NSC-758395; SDCCGMLS-0066659.P001; (-)-TRANS-P-METHAN-CIS-3-OL; IDI1_000820; WLN: L6TJ AY1&1 DQ D1 -L; NCGC00164247-01; NCGC00164247-02; NCGC00164247-03; NCGC00256525-01; NCGC00256561-01; NCGC00259372-01; NCGC00259468-01; NCGC00260156-01; FEMA NO. 2665; (-)-; SMR001306785; L-Menthol; natural; >=99%; FCC; FG; SBI-0051777.P002; NS00068027; NS00102112; S5868; EN300-92163; FEMA NO. 2665; (+/-)-; Menthol (racemic) 100 microg/mL in Methanol; (+/-)-(1R*;3R*;4S*)-MENTHOL; (1R;2S;5R)-(-)-Menthol; synthetic pellets; C00400; Cyclohexanol; (1.alpha.;2.beta.;5.alpha.)-; D00064; D70313; (1R;2R;5S)-2-isopropyl-5-methyl-cyclohexanol; AB00052320_02; L-Menthol|Levomenthol|Menthomenthol|Menthacamphor; (1R;2S;5R)-(-)-Menthol; >=99%; sublimed; A843308; Q407418; Q-201316; SR-05000001936-1; SR-05000001936-2; (-)-Menthol; primary pharmaceutical reference standard; (1R;2S;5R)-(-)-Menthol; ReagentPlus(R); 99%; 2-Isopropyl-5-methylcyclohexanol-; (1R;2S;5R)- #; Cyclohexanol; [1R-(1.alpha.;2.beta.;5.alpha.)]-; (1R;2S;5R)-5-methyl-2-propan-2-yl-cyclohexan-1-ol; Z1255438640; (1R;2S;5R)-(-)-Menthol; Vetec(TM) reagent grade; 98%; 6C6A4A8C-A054-468C-A1F0-F29E39838CF2; (1R; 2S; 5R)-5-methyl-2-(1-methylethyl)cyclohexyl alcohol; Menthol; United States Pharmacopeia (USP) Reference Standard; (1R;2S;5R)-REL-5-METHYL-2-(1-METHYLETHYL)CYCLOHEXANOL; L-Menthol; Pharmaceutical Secondary Standard; Certified Reference Material; (-)-Menthol; puriss.; meets analytical specification of Ph. Eur.; BP; USP; 98.0-102.0%; (1R-(1-.alpha.;2-.beta.;5-.alpha.))-5-Methyl-2-(1-methylethyl)cyclohexanol; 114376-98-6; InChI=1/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H;4-6H2;1-3H3/t8-;9+;10-/m1/s1]

InChI Key

NOOLISFMXDJSKH-KXUCPTDWSA-N

InChI

InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m1/s1

IUPAC Name

(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol

CAS Number

80952-71-2

Structure Information

Chemical Structure Visualization

SMILES Notation

2D Molecular Drawing

Carbon (C)

Hydrogen (H)

Oxygen (O)

Nitrogen (N)

Sulfur (S)

SDF

31 31 0 0 0 0 0 0 0 0999 V2000
3.5611 0.1077 0.0478 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2163 0.7926 -0.2305 C 0 0 2 0 0 0 0 0 0 0 0 0
1.4227 0.987...

Download SDF File (2650 bytes)

Experimental Data

Activity Data

Target Ion Channel

Transient receptor potential cation channel subfamily M member 8

Uniprot Accession Number

Q7Z2W7

Function

Antagonist

Species

Homo sapiens (Human)

IC₅₀

IC₅₀: 5.7 nM

EC₅₀

N/A (Not available)

K_i

N/A (Not available)

K_d

N/A (Not available)

Inhibition

N/A (Not available)

Experimental Conditions

Extracellular solution pH 7.4/Intracellular solution pH 7.2

Holding Potential

80 mV mV

Temperature

23 ± 1 °C

Test Method

Patch-clamping

Test Species

HEK293 cell (Homo sapiens embryonic kidney 293 cell)

Binding Information

Binding Site

Not specified

Binding Site Residue

Not specified

Disease Information

Related Disease

Not specified

References

DOI

10.1021/acschemneuro.9b00404

URL

N/A (Not available)

PMID

31850745

Patent

N/A (Not available)

Computed Properties

Heavy Atom Count

Rotatable Bonds

logP

2.4395

Complexity

47.3498

TPSA (Å²)

20.23

H-Bond Donors

H-Bond Acceptors

Ring Count

New Search

Molecular Details

Basic Molecular Information

Basic Information

Structure Information

Chemical Structure Visualization

Experimental Data

Activity Data

Experimental Conditions

Binding Information

Disease Information

References

Computed Properties